PJ

Pravin Jain

Active Director Whole-Time Director DIN 00205927
DIN 00205927 First appointment Feb 1996 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 11 active board seats
Total affiliations 11 Since Feb 1996
Shareholding value •••• Premium profile

About Pravin Jain

Data last updated:

Pravin Jain is a Whole-Time Director at Neon Laboratories Limited (since 1996), Director at Vhb Medi Sciences Limited (since 2012) and Director at Sndev Healthcare Limited (since 2008), and holds 8 more current directorships. The companies operate in Pharma, Chemicals and Healthcare. The 9 current companies with reported revenue have a combined latest revenue of ₹1,532 Cr; the largest is Neon Laboratories Limited at ₹1,223 Cr (FY 2025).

DIN 00205927
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 06 Feb 1996
Oldest Company Age 44 yrs
Largest company Neon Laboratories Limited · ₹1,223 Cr (FY 2025)
Combined revenue ₹1,532 Cr across 9 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neon Laboratories Limited U24100MH1982PLC027493
Whole-Time Director06 Feb 19961982₹1,223 Cr (FY 2025)Active
Vhb Medi Sciences Limited U24232MH2007PLC174054
Director27 Sep 20122007₹159 Cr (FY 2025)Active
Sndev Healthcare Limited U24233MH2005PLC369596
Director24 Mar 20082005₹55.17 Cr (FY 2025)Active
Surajlok Chemicals Private Limited U24112MH1991PTC059944
Director19 Mar 20141991₹46.83 Cr (FY 2025)Active
Director15 Feb 20141990₹33.11 Cr (FY 2025)Active
Vhb Life Sciences Limited U74900MH2007PLC171648
Whole-Time Director27 Sep 20122007₹13.99 Cr (FY 2025)Active
Director11 Feb 20092003₹14 Lakh (FY 2016)Active
Riddhi Pharmaceuticals Limited U24230MH1995PLC094749
Director10 Mar 20141995₹12.2 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Surajlok Chemicals Private Limited
Riddhi Pharmaceuticals Limited
Yog Divakar Realtors And Investors Private Limited
Vhb Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pravin Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pravin Jain

Pravin Jain currently holds 11 directorships: Neon Laboratories Limited (Whole-Time Director, since 06 Feb 1996, revenue ₹1,223 Cr (FY 2025)); Vhb Medi Sciences Limited (Director, since 27 Sep 2012, revenue ₹159 Cr (FY 2025)); Sndev Healthcare Limited (Director, since 24 Mar 2008, revenue ₹55.17 Cr (FY 2025)); Surajlok Chemicals Private Limited (Director, since 19 Mar 2014, revenue ₹46.83 Cr (FY 2025)); Korten Pharmaceuticals Private Limited (Director, since 15 Feb 2014, revenue ₹33.11 Cr (FY 2025)); and 6 more.

Pravin Jain was first appointed on 06 Feb 1996 as Whole-Time Director at Neon Laboratories Limited. The most recent appointment on record is 24 Nov 2025 at Tjp Infra Llp.

The 9 current companies of Pravin Jain that report revenue have a combined latest revenue of ₹1,532 Cr: Neon Laboratories Limited ₹1,223 Cr (FY 2025); Vhb Medi Sciences Limited ₹159 Cr (FY 2025); Sndev Healthcare Limited ₹55.17 Cr (FY 2025); Surajlok Chemicals Private Limited ₹46.83 Cr (FY 2025); Korten Pharmaceuticals Private Limited ₹33.11 Cr (FY 2025); and 4 more.

The current boards of Pravin Jain's companies include Abhay Uttamchand Jain (Neon Laboratories Limited), Ashokkumar Keshrimal Jain (Neon Laboratories Limited), Hemali Pankaj Lodha (Neon Laboratories Limited), Hitesh Kiran Kumar (Neon Laboratories Limited), Siddharth Bhikchand Bhansali (Neon Laboratories Limited), Uttamchand Kesharimal Jain (Neon Laboratories Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available